− Approval Based on Results from Positive, Global, Phase 3 FRESCO-2 Trial − FRUZAQLA (fruquintinib) is the First Novel Targeted Therapy in Japan...

A promising new therapy for medlinktuberculosis/medlink (TB) has been shown to be compatible with combined antiretroviral therapy (cART), stated...

New research findings of the ENZAMET (ANZUP 1304) study, led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP),...

Results from a preclinical study in mice, and a collaborative clinical study in patients show that the type 2 immune response – associated with...

Given that human trials on the use of psychedelic drugs to treat anxiety and depression are underway in different parts of the globe, the TIFR-led...

A study reveals that voice-activated cognitive behavioral therapy significantly improves insomnia symptoms in breast cancer survivors, enhancing...

TUESDAY, Oct. 1, 2024 -- Patients with fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study...

Amongst women who experience recurrent pregnancy loss, around 20% test positive for a specific antibody that targets the mother's own body. A Kobe...

The beauty trend that uses near-infrared light waves has surged in popularity – but can you achieve results at home?

President Akufo-Addo has stated that Ghanaians have consistently shown a deep and unwavering commitment to democracy. Speaking at the 78th session of...